ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » General Practice

Top General Practice Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ERIC ROMANOWSKY M.D.

General Practice

18,451

$1.18M

482
378 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$64
Average prescription price

Avg: $55

GABRIEL YUIL MD

General Practice

11,107

$546K

377
250 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $55

GLORIA MERCADO M.D.

General Practice

7,597

$301K

343
136 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$40
Average prescription price

Avg: $55

FERNANDO JAYMA M.D.

General Practice

6,522

$388K

237
90 are 65+

52%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 21%

$60
Average prescription price

Avg: $55

PAUL COCHRANE DO

General Practice

5,577

$263K

247
182 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$47
Average prescription price

Avg: $55

MARTHA LIPCHITZ M.D.

General Practice

5,215

$308K

149
93 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$59
Average prescription price

Avg: $55

PRIYA NANDI MD

General Practice

4,698

$219K

103
57 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$47
Average prescription price

Avg: $55

WILFRID PITTS MD

General Practice

4,581

$242K

150
88 are 65+

37%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $55

HIEP NGUYEN M.D.

General Practice

3,834

$206K

232
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $55

JOHN YEE MD

General Practice

3,151

$187K

232
171 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 21%

$59
Average prescription price

Avg: $55

HUNG DO M.D.

General Practice

2,904

$76.1K

226
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 8%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 21%

$26
Average prescription price

Avg: $55

KENT HESSE M.D.

General Practice

2,566

$297K

187
20 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 21%

$116
Average prescription price

Avg: $55

CHARLES WEEBER MD

General Practice

2,506

$132K

167
121 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $55

MARK URMAN M.D.

General Practice

2,425

$171K

80
55 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 21%

$70
Average prescription price

Avg: $55

DALE ANTANITUS M.D.

General Practice

2,343

$97.9K

51
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $55

MALATHI BHAT MD

General Practice

1,948

$150K

127
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 21%

$77
Average prescription price

Avg: $55

REBEKKA TARATUTA M.D.

General Practice

1,877

$64K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 21%

$34
Average prescription price

Avg: $55

JULIETA AUSTRIA M.D.

General Practice

1,805

$71.7K

61
52 are 65+

26%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 21%

$40
Average prescription price

Avg: $55

NEETA OHRI M.D.

General Practice

1,797

$57.5K

101
46 are 65+

25%
patients receiving schedule two controlled substances

Avg: 14%

15%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 21%

$32
Average prescription price

Avg: $55

RONALD EGAN M.D.

General Practice

1,751

$61K

54
19 are 65+

59%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 21%

$35
Average prescription price

Avg: $55

ROBERT TAYLOR M.D.

General Practice

1,494

$71.9K

132
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$48
Average prescription price

Avg: $55

LISA ZANDONELLA-HUHTA M.D.

General Practice

1,267

$58.4K

81
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

36%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $55

DUC CHU M.D.

General Practice

1,126

$34.5K

74
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 21%

$31
Average prescription price

Avg: $55

LISA HARVEY M.D.

General Practice

920

$70.8K

211
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 21%

$77
Average prescription price

Avg: $55

ANJANA CHAKRABARTI MD

General Practice

914

$45K

148
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $55

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank